investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Extraordinary responder cell lines reveal unique targetable genetic dependencies
Hugh S. Gannon
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Hugh S. Gannon
Dana-Farber Cancer Institute
Boston, United States
Related projects
Amato J Giaccia
Tumor Hypoxia: Molecular Studies and Clinical Exploitation
Breast
Radiation Oncology
Carlo M Croce
MiRNAs/UCRs: Biomarkers for Cancer Risk, Tumor Detection, Progression and Treatment
Breast
Mala Pande
Susceptibility Markers for a Breast-Colon Cancer Phenotype
Breast
Heather Elizabeth Wheeler
Pharmacogenomics of the Chemotherapeutic Agent Paclitaxel
Breast
Joseph Barchi
Carbohydrate Antigen-bearing Nanoparticles for Anti-adhesives and Tumor Vaccines
Breast
W Todd Miller
Substrate Specificity of Non-receptor Tyrosine Kinases
Breast
Shridar Ganesan
53BP1-Mediated Regulation of DNA Repair and Chemoresistance
Breast
Martin E Hemler
Support of carcinoma metastasis by integrin a6-CD151-PKC complexes
Breast
Kent Hunter
Genetic Modifiers of Initiation and Progression of Mammary Cancer
Breast